Literature DB >> 22414807

Glucose-mediated control of ghrelin release from primary cultures of gastric mucosal cells.

Ichiro Sakata1, Won-Mee Park, Angela K Walker, Paul K Piper, Jen-Chieh Chuang, Sherri Osborne-Lawrence, Jeffrey M Zigman.   

Abstract

The peptide hormone ghrelin is released from a distinct group of gastrointestinal cells in response to caloric restriction, whereas its levels fall after eating. The mechanisms by which ghrelin secretion is regulated remain largely unknown. Here, we have used primary cultures of mouse gastric mucosal cells to investigate ghrelin secretion, with an emphasis on the role of glucose. Ghrelin secretion from these cells upon exposure to different d-glucose concentrations, the glucose antimetabolite 2-deoxy-d-glucose, and other potential secretagogues was assessed. The expression profile of proteins involved in glucose transport, metabolism, and utilization within highly enriched pools of mouse ghrelin cells and within cultured ghrelinoma cells was also determined. Ghrelin release negatively correlated with d-glucose concentration. Insulin blocked ghrelin release, but only in a low d-glucose environment. 2-Deoxy-d-glucose prevented the inhibitory effect of high d-glucose exposure on ghrelin release. mRNAs encoding several facilitative glucose transporters, hexokinases, the ATP-sensitive potassium channel subunit Kir6.2, and sulfonylurea type 1 receptor were expressed highly within ghrelin cells, although neither tolbutamide nor diazoxide exerted direct effects on ghrelin secretion. These findings suggest that direct exposure of ghrelin cells to low ambient d-glucose stimulates ghrelin release, whereas high d-glucose and glucose metabolism within ghrelin cells block ghrelin release. Also, low d-glucose sensitizes ghrelin cells to insulin. Various glucose transporters, channels, and enzymes that mediate glucose responsiveness in other cell types may contribute to the ghrelin cell machinery involved in regulating ghrelin secretion under these different glucose environments, although their exact roles in ghrelin release remain uncertain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22414807      PMCID: PMC3361986          DOI: 10.1152/ajpendo.00041.2012

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  64 in total

1.  Mice lacking ghrelin receptors resist the development of diet-induced obesity.

Authors:  Jeffrey M Zigman; Yoshihide Nakano; Roberto Coppari; Nina Balthasar; Jacob N Marcus; Charlotte E Lee; Juli E Jones; Amy E Deysher; Amanda R Waxman; Ryan D White; Todd D Williams; Jennifer L Lachey; Randy J Seeley; Bradford B Lowell; Joel K Elmquist
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

2.  In vitro insulin secretion by pancreatic tissue from infants with diazoxide-resistant congenital hyperinsulinism deviates from model predictions.

Authors:  Jean-Claude Henquin; Myriam Nenquin; Christine Sempoux; Yves Guiot; Christine Bellanné-Chantelot; Timo Otonkoski; Pascale de Lonlay; Claire Nihoul-Fékété; Jacques Rahier
Journal:  J Clin Invest       Date:  2011-09-26       Impact factor: 14.808

3.  Ghrelin action in the brain controls adipocyte metabolism.

Authors:  Claudia Theander-Carrillo; Petra Wiedmer; Philippe Cettour-Rose; Ruben Nogueiras; Diego Perez-Tilve; Paul Pfluger; Tamara R Castaneda; Patrick Muzzin; Annette Schürmann; Ildiko Szanto; Matthias H Tschöp; Françoise Rohner-Jeanrenaud
Journal:  J Clin Invest       Date:  2006-06-08       Impact factor: 14.808

4.  ATP-sensitive K+ channel-dependent regulation of glucagon release and electrical activity by glucose in wild-type and SUR1-/- mouse alpha-cells.

Authors:  Jesper Gromada; Xiaosong Ma; Marianne Høy; Krister Bokvist; Albert Salehi; Per-Olof Berggren; Patrik Rorsman
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

5.  Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice.

Authors:  Yuxiang Sun; Mark Asnicar; Pradip K Saha; Lawrence Chan; Roy G Smith
Journal:  Cell Metab       Date:  2006-05       Impact factor: 27.287

6.  Beta-cell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release.

Authors:  Isobel Franklin; Jesper Gromada; Asllan Gjinovci; Sten Theander; Claes B Wollheim
Journal:  Diabetes       Date:  2005-06       Impact factor: 9.461

7.  Peripheral ghrelin participates in the glucostatic signaling mediated by the ventromedial and lateral hypothalamus neurons.

Authors:  Andrew Solomon; Brant A De Fanti; J Alfredo Martínez
Journal:  Peptides       Date:  2006-03-30       Impact factor: 3.750

8.  Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents.

Authors:  Madhusmita Misra; Karen K Miller; Kelly Kuo; Kathryn Griffin; Victoria Stewart; Emily Hunter; David B Herzog; Anne Klibanski
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-03-08       Impact factor: 4.310

9.  Ghrelin controls hippocampal spine synapse density and memory performance.

Authors:  Sabrina Diano; Susan A Farr; Stephen C Benoit; Ewan C McNay; Ivaldo da Silva; Balazs Horvath; F Spencer Gaskin; Naoko Nonaka; Laura B Jaeger; William A Banks; John E Morley; Shirly Pinto; Robert S Sherwin; Lin Xu; Kelvin A Yamada; Mark W Sleeman; Matthias H Tschöp; Tamas L Horvath
Journal:  Nat Neurosci       Date:  2006-02-19       Impact factor: 24.884

10.  Direct stimulation of ghrelin secretion by sympathetic nerves.

Authors:  Thomas O Mundinger; David E Cummings; Gerald J Taborsky
Journal:  Endocrinology       Date:  2006-03-09       Impact factor: 4.736

View more
  42 in total

1.  A Strong Stomach for Somatostatin.

Authors:  Bharath K Mani; Jeffrey M Zigman
Journal:  Endocrinology       Date:  2015-11       Impact factor: 4.736

2.  The next big LEAP2 understanding ghrelin function.

Authors:  Zane B Andrews
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

3.  Jejunal administration of glucose enhances acyl ghrelin suppression in obese humans.

Authors:  Robyn A Tamboli; Reem M Sidani; Anna E Garcia; Joseph Antoun; James M Isbell; Vance L Albaugh; Naji N Abumrad
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-06-07       Impact factor: 4.310

Review 4.  Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis.

Authors:  Charlotte X Dong; Patricia L Brubaker
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-10-02       Impact factor: 46.802

5.  Improved post-prandial ghrelin response by nateglinide or acarbose therapy contributes to glucose stability in Type 2 diabetic patients.

Authors:  F Zheng; X Yin; W Lu; J Zhou; H Yuan; H Li
Journal:  J Endocrinol Invest       Date:  2013-01-14       Impact factor: 4.256

6.  Role of Enteroendocrine Hormones in Appetite and Glycemia.

Authors:  Maria Laura Ricardo-Silgado; Alison McRae; Andres Acosta
Journal:  Obes Med       Date:  2021-03-12

7.  Hypoglycemic Effect of Combined Ghrelin and Glucagon Receptor Blockade.

Authors:  Bharath K Mani; Aki Uchida; Young Lee; Sherri Osborne-Lawrence; Maureen J Charron; Roger H Unger; Eric D Berglund; Jeffrey M Zigman
Journal:  Diabetes       Date:  2017-05-09       Impact factor: 9.461

Review 8.  Mechanisms of the amplifying pathway of insulin secretion in the β cell.

Authors:  Michael A Kalwat; Melanie H Cobb
Journal:  Pharmacol Ther       Date:  2017-05-18       Impact factor: 12.310

9.  Acyl-ghrelin Is Permissive for the Normal Counterregulatory Response to Insulin-Induced Hypoglycemia.

Authors:  Kripa Shankar; Deepali Gupta; Bharath K Mani; Brianna G Findley; Caleb C Lord; Sherri Osborne-Lawrence; Nathan P Metzger; Claudio Pietra; Chen Liu; Eric D Berglund; Jeffrey M Zigman
Journal:  Diabetes       Date:  2019-11-04       Impact factor: 9.461

10.  Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells.

Authors:  Maja S Engelstoft; Won-Mee Park; Ichiro Sakata; Line V Kristensen; Anna Sofie Husted; Sherri Osborne-Lawrence; Paul K Piper; Angela K Walker; Maria H Pedersen; Mark K Nøhr; Jie Pan; Christopher J Sinz; Paul E Carrington; Taro E Akiyama; Robert M Jones; Cong Tang; Kashan Ahmed; Stefan Offermanns; Kristoffer L Egerod; Jeffrey M Zigman; Thue W Schwartz
Journal:  Mol Metab       Date:  2013-09-04       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.